Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Purchase individual online access for 1 year to this journal.
Price: EUR 595.00Impact Factor 2024: 3.4
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease.
The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
Authors: Cicconi, Simona | Gentile, Antonietta | Ciotti, Maria Teresa | Parasassi, Tiziana | Serafino, Annalucia | Calissano, Pietro
Article Type: Research Article
Abstract: In this study we report that apoptotic death of primary cultures of cerebellar granule neurons is accompanied by release of thioflavin-binding proteins – indicative of the presence of β-sheet structures – and fibril formation in the culture medium. When the same neurons are subjected to an excytotoxic death caused by 100 µM glutamate exposure, the amount of thioflavin binding is markedly reduced. Western blot analysis shows that fibrils contain monomers, dimers and trimers of amyloid-β (Aβ) which, when observed at the electron microscope, have morphologies reminiscent of fibrils of senile plaques. These findings demonstrate that triggering an apoptotic pathway leads …to β-sheet transition and fibril formation of a protein primarily involved in Alzheimer's disease and may be of direct relevance to the possible link between apoptosis and this neuropathology. Show more
Keywords: Apoptosis, necrosis, β-sheet structures, Aβ, CGNs
DOI: 10.3233/JAD-2007-12301
Citation: Journal of Alzheimer's Disease, vol. 12, no. 3, pp. 211-220, 2007
Authors: Vendramini, Alex Augusto | de Lábio, Roger Willian | Rasmussen, Lucas Trevisani | Minett, Thais | Bertolucci, Paulo Henrique Ferreira | de Arruda Cardoso Smith, Marília | Payão, Spencer Luiz Marques
Article Type: Short Communication
Keywords: Ageing, Alzheimer's disease, interleukin-8, -251T→A polymorphisms, risk factor
DOI: 10.3233/JAD-2007-12302
Citation: Journal of Alzheimer's Disease, vol. 12, no. 3, pp. 221-222, 2007
Authors: Ferreiro, Elisabete | Eufrásio, Ana | Pereira, Cláudia | Oliveira, Catarina R. | Rego, A. Cristina
Article Type: Research Article
Abstract: In this study we analysed the effect of Bcl-2 on the cytotoxicity induced by the amyloid-β (Aβ25–35 ) and prion (PrP106–126 ) peptides by using GT1-7 puro and GT1-7 bcl-2 (overexpressing the anti-apoptotic protein Bcl-2) neural cells. Exposure to Aβ25–35 (1–5 μM) and PrP106–126 (25 μM) caused a decrease in cell viability, as determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. These data were correlated with Aβ25–35 and PrP106–126 -induced activation of caspase-9, which is linked to the mitochondrial death pathway, and the activation of the effector caspase-3, suggesting cell death by apoptosis. Furthermore, Bcl-2 overexpression protected from …loss of cell viability and caspase-9 and -3 activation induced by Aβ25–35 and PrP106–126 , showing that Bcl-2 is neuroprotective against apoptotic cell death caused by amyloidogenic peptides. Show more
Keywords: Amyloid-β peptide, prion peptide, caspases, cell death, GT1-7 cells
DOI: 10.3233/JAD-2007-12303
Citation: Journal of Alzheimer's Disease, vol. 12, no. 3, pp. 223-228, 2007
Authors: López-Toledano, Miguel A. | Shelanski, Michael L.
Article Type: Research Article
Abstract: APP overexpressing mice have been widely used in the study of Alzheimer's disease (AD), focusing mainly at older ages, with higher accumulation of amyloid-β peptide (Aβ). A decrease in hippocampal adult neurogenesis has been described in these models and proposed to be a consequence of Aβ accumulation. Only one study demonstrates increased neurogenesis in the hippocampus of APP-overexpressing J20 mice, and suggests it is a compensatory effect due to a subtle Aβ-induced damage. We have previously reported that a specific aggregation of Aβ has neurogenic potential on neural stem cells (NSC) in vitro. In order to clarify the contradicting data …reported in vivo, we investigated NSC proliferation and neuronal differentiation in the hippocampi of J20 mice at a broader range of ages. Using immunohistochemistry, we show increased proliferation and neuronal differentiation in the hippocampi of 3 month-old J20 mice that reverted when animals became older. The increase in neurogenesis correlated with detectable levels of oligomeric Aβ, measured by ELISA and western blot. We suggest that oligomeric Aβ directly induces neurogenesis in vivo as has been demonstrated in vitro. Understanding the mechanisms underlying these changes could lead to treatments to control the neuronal differentiation of endogenous precursors through the progress of AD. Show more
Keywords: Alzheimer, J20, PDGF-APPSw,Ind overexpressing transgenic mice Hippocampus, Neurogenesis, amyloid-β peptide
DOI: 10.3233/JAD-2007-12304
Citation: Journal of Alzheimer's Disease, vol. 12, no. 3, pp. 229-240, 2007
Authors: Toohey, John I.
Article Type: Research Article
Abstract: There has been evidence for a causal relationship between homocysteine and Alzheimer's disease for several years but the mechanism is unclear. In vivo, some homocysteine is converted to the thiolactone. This report describes a novel reaction between homocysteine thiolactone and dehydroascorbic acid in which the homocysteine thiolactone is converted to 3-mercaptopropionaldehyde. This product is shown to react with proteins causing their precipitation (probably by cross-linking). The two reactions are extremely facile and appear to be physiologically compatible suggesting a mechanism by which homocysteine may promote the deposition of proteins in nerve cells as amyloid plaques and fibrillary tangles.
Keywords: Dehydroascorbic acid, homocysteine thiolactone, Alzheimer's disease, amyloid plaques, amyloid diseases
DOI: 10.3233/JAD-2007-12305
Citation: Journal of Alzheimer's Disease, vol. 12, no. 3, pp. 241-243, 2007
Authors: Ueki, Akinori | Ueno, Hideo | Sato, Noriko | Shinjo, Hidetaka | Morita, Yoshio
Article Type: Research Article
Abstract: The purpose of the present study was to confirm an association of functional polymorphism within the serotonin transporter (5-HTT) gene with Alzheimer's disease (AD) and behavioral and psychological symptoms of dementia (BPSD) in mild AD. Apolipoprotein E (ApoE) gene polymorphism and 2 types of functional polymorphism in the 5-HTT gene, 5-HTT-linked polymorphic region (5-HTTLPR) and a 5-HTT variable number of tandem repeats sequence (5-HTTVNTR) were analyzed longitudinally in outpatients with mild AD to find out whether there was a relation between any such polymorphisms and the occurrence of BPSD. No significant differences in genotype distribution or allele frequencies were identified …for 5-HTTLPR or 5-HTTVNTR between AD patients and age- and sex-matched non-demented controls regardless of ApoE ε4 allele. No significant differences were noted in 5-HTTLPR genotype or allele distributions between AD patients with or without BPSD. However, significant associations were observed between presence of 5-HTTVNTR allele 10 and BPSD or aggressiveness. This difference was independent of the presence of the ApoE ε4 allele. As a result, 5-HTT polymorphisms are unlikely to play any substantial role in susceptibility to AD. Conversely, 5-HTTVNTR influences the risk of developing BPSD or aggressiveness and genetic variations in the 5-HTT gene may be involved in the development of symptomatology for mild AD. Show more
Keywords: Serotonin transporter, genetic, polymorphism, Alzheimer's disease, behavioral and psychological symptoms of dementia, aggressiveness
DOI: 10.3233/JAD-2007-12306
Citation: Journal of Alzheimer's Disease, vol. 12, no. 3, pp. 245-253, 2007
Authors: Zetterberg, Henrik | Pedersen, Mona | Lind, Karin | Svensson, Maria | Rolstad, Sindre | Eckerström, Carl | Syversen, Steinar | Mattsson, Ulla-Britt | Ysander, Christina | Mattsson, Niklas | Nordlund, Arto | Vanderstichele, Hugo | Vanmechelen, Eugeen | Jonsson, Michael | Edman, Åke | Blennow, Kaj | Wallin, Anders
Article Type: Research Article
Abstract: This study examines the intra-individual stability of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) over 2 years in 83 patients with mild cognitive impairment (MCI) and 17 cognitively healthy control individuals. All participants underwent clinical and neuropsychological evaluation and lumbar puncture at baseline and after 2 years at a university hospital memory clinic. CSF was analyzed for total tau (T-tau), phospho-tau181 (P-tau181 ) and amyloid-β1–42 (Aβ1–42 ). During the 2-year observational time, 12 MCI patients progressed to AD and 3 progressed to vascular dementia, while 68 remained stable. Baseline T-tau and P-tau181 levels were elevated in …the MCI-AD group as compared to the stable MCI patients and the control group (p < 0.01 ), while baseline Aβ1–42 levels were lower (p < 0.001 ). Stable MCI patients were biochemically indistinguishable from controls. The biomarker levels at baseline and after 2 years showed Pearson R values between 0.81 and 0.91 (p < 0.001 ) and coefficients of variation of 7.2 to 8.7%. In conclusion, intra-individual biomarker levels are remarkably stable over 2 years. Thus, even minor biochemical changes induced by treatment against AD should be detectable using these biomarkers, which bodes well for their usefulness as surrogate markers for drug efficacy in clinical trials. Show more
Keywords: Mild cognitive impairment, Alzheimer's disease, cerebrospinal fluid, biomarkers, longitudinal study, tau, amyloid-β (Aβ), stability
DOI: 10.3233/JAD-2007-12307
Citation: Journal of Alzheimer's Disease, vol. 12, no. 3, pp. 255-260, 2007
Authors: Chander, Harish | Chauhan, Abha | Chauhan, Ved
Article Type: Research Article
Abstract: Fibrillar amyloid-β protein (fAβ) is the principal component of amyloid plaques in the brains of patients with Alzheimer's disease (AD). We have recently reported that activity of trypsin is inhibited by fAβ and that trypsin can bind to fAβ. Neprilysin and insulysin are important proteases for the clearance of soluble Aβ. Here, we report that fAβ also binds to neprilysin and insulysin, which results in the inhibition of their proteolytic activities. These findings suggest that clearance of soluble Aβ may be defective in AD because of binding of proteases to amyloid plaques, leading to inactivation of proteases that are required …for catabolism of Aβ. The identification of compounds that can inhibit binding of proteases to fAβ may, therefore, be of significance for therapeutic intervention in AD. Congo red and Thioflavin T are widely used for histopathological examination of amyloid plaques because of their strong affinity to fibrillar amyloid proteins. We examined the effect of Congo red and Thioflavin T (potent fAβ-binding compounds) on the binding of different proteases to fAβ. While Congo red inhibited the binding of trypsin, neprilysin and insulysin to fAβ, Thioflavin T did not have any effect. The effect of Congo red was concentration-dependent and the inhibitory effect was in the order of trypsin > insulysin > neprilysin. When the effect of prebound-Congo red to fAβ was examined, trypsin was unable to bind to this complex suggesting that Congo red may have better affinity than trypsin for binding to fAβ. Based on these results, we propose that the inhibition of binding of proteases to amyloid plaques may help in reducing the deposition of Aβ in AD. Show more
Keywords: Alzheimer's disease, amyloid-β protein, amyloid plaque, fibrillization, insulysin, neprilysin, proteases, trypsin
DOI: 10.3233/JAD-2007-12308
Citation: Journal of Alzheimer's Disease, vol. 12, no. 3, pp. 261-269, 2007
Authors: Youn, HyeSook | Ji, Inhae | Ji, Hanlee P. | Markesbery, William R. | Ji, Tae H.
Article Type: Research Article
Abstract: Recently, it has been reported that Kalirin gene transcripts are under-expressed in AD hippocampal specimens compared to the controls. The Kalirin gene generates a dozen Kalirin isoforms. Kalirin-7 is the predominant protein expressed in the adult brain and plays crucial roles in growth and maintenance of neurons. Yet its role in human diseases is unknown. We report that Kalirin-7 is significantly diminished both at the mRNA and protein levels in the hippocampus specimens from 19 AD patients compared to the specimens from 15 controls. Kalirin-7 associates with iNOS in the hippocampus, and therefore, Kalirin-7 is complexed with iNOS less …in AD hippocampus extracts than in control hippocampus extracts. In cultured cells, Kalirin-7 associates with iNOS and down-regulates the enzyme activity. The down-regulation is attributed to the highly conserved 33 amino acid sequence, K617 -H649 , of the 1,663 amino acids long Kalirin-7. Remarkably, the iNOS activity is considerably higher in the hippocampus specimens from AD patients than the specimens from 15 controls. These observations suggest that the under-expression of Kalirin-7 in AD hippocampus correlates to the elevated iNOS activity. Show more
Keywords: Kalirin, iNOS suppression, Alzheimer's disease, AD, hippocampus
DOI: 10.3233/JAD-2007-12309
Citation: Journal of Alzheimer's Disease, vol. 12, no. 3, pp. 271-281, 2007
Article Type: Announcement
DOI: 10.3233/JAD-2007-12310
Citation: Journal of Alzheimer's Disease, vol. 12, no. 3, pp. 283-284, 2007
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]